Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing

Background: The detection of <i>CEBPA</i> and <i>FLT3</i> mutations by next generation sequencing (NGS) is challenging due to high GC content and Internal Tandem Duplications (ITDs). Recent advances have been made to surmount these challenges. In this study, we compare three...

Full description

Bibliographic Details
Main Authors: Ratilal Akabari, Dahui Qin, Mohammad Hussaini
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/13/4/630
_version_ 1797434656508870656
author Ratilal Akabari
Dahui Qin
Mohammad Hussaini
author_facet Ratilal Akabari
Dahui Qin
Mohammad Hussaini
author_sort Ratilal Akabari
collection DOAJ
description Background: The detection of <i>CEBPA</i> and <i>FLT3</i> mutations by next generation sequencing (NGS) is challenging due to high GC content and Internal Tandem Duplications (ITDs). Recent advances have been made to surmount these challenges. In this study, we compare three commercial kits and evaluate the performance of these more advanced hybrid-capture and AMP-chemistry based methods. Methods: Amplicon-based TSM 54-Gene Panel (Illumina) was evaluated against hybridization-capture SOPHiA Genetics MSP, OGT SureSeq, and AMP chemistry-based VariantPlex (Archer) for wet-lab workflow and data-analysis pipelines. Standard kit directions and commercial analysis pipelines were followed. Seven <i>CEBPA</i> and 10 <i>FLT3</i>-positive cases were identified that previously were missed on an amplicon NGS assay. The average reads, coverage uniformity, and the detection of <i>CEBPA</i> or <i>FLT3</i> mutations were compared. Results: All three panels detected all 10 <i>CEBPA</i> mutations and all 10 <i>FLT3</i> ITDs with 100% sensitivity. In addition, there was high concordance (100%) between all three panels detecting 47/47 confirmed variants in a set of core myeloid genes. Conclusions: The results show that the NGS assays are now able to reliably detect <i>CEBPA</i> mutations and <i>FLT3</i> ITDs. These assays may allow foregoing additional orthogonal testing for <i>CEBPA</i> and <i>FLT3</i>.
first_indexed 2024-03-09T10:36:32Z
format Article
id doaj.art-b94096b073f945c1b2d3cc47b00fcce9
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-09T10:36:32Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-b94096b073f945c1b2d3cc47b00fcce92023-12-01T20:57:03ZengMDPI AGGenes2073-44252022-04-0113463010.3390/genes13040630Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation SequencingRatilal Akabari0Dahui Qin1Mohammad Hussaini2Department of Pathology, Molecular Oncology and Genetics Diagnostics, SUNY Upstate Medical University, Syracuse, NY 13210, USADepartment of Pathology, Moffitt Cancer Center, Tampa, FL 33612, USADepartment of Pathology, Moffitt Cancer Center, Tampa, FL 33612, USABackground: The detection of <i>CEBPA</i> and <i>FLT3</i> mutations by next generation sequencing (NGS) is challenging due to high GC content and Internal Tandem Duplications (ITDs). Recent advances have been made to surmount these challenges. In this study, we compare three commercial kits and evaluate the performance of these more advanced hybrid-capture and AMP-chemistry based methods. Methods: Amplicon-based TSM 54-Gene Panel (Illumina) was evaluated against hybridization-capture SOPHiA Genetics MSP, OGT SureSeq, and AMP chemistry-based VariantPlex (Archer) for wet-lab workflow and data-analysis pipelines. Standard kit directions and commercial analysis pipelines were followed. Seven <i>CEBPA</i> and 10 <i>FLT3</i>-positive cases were identified that previously were missed on an amplicon NGS assay. The average reads, coverage uniformity, and the detection of <i>CEBPA</i> or <i>FLT3</i> mutations were compared. Results: All three panels detected all 10 <i>CEBPA</i> mutations and all 10 <i>FLT3</i> ITDs with 100% sensitivity. In addition, there was high concordance (100%) between all three panels detecting 47/47 confirmed variants in a set of core myeloid genes. Conclusions: The results show that the NGS assays are now able to reliably detect <i>CEBPA</i> mutations and <i>FLT3</i> ITDs. These assays may allow foregoing additional orthogonal testing for <i>CEBPA</i> and <i>FLT3</i>.https://www.mdpi.com/2073-4425/13/4/630<i>CEBPA</i><i>FLT3</i>AMLnext generation sequencing (NGS)Internal Tandem Duplication (ITD)
spellingShingle Ratilal Akabari
Dahui Qin
Mohammad Hussaini
Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing
Genes
<i>CEBPA</i>
<i>FLT3</i>
AML
next generation sequencing (NGS)
Internal Tandem Duplication (ITD)
title Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing
title_full Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing
title_fullStr Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing
title_full_unstemmed Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing
title_short Technological Advances: <i>CEBPA</i> and <i>FLT3</i> Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing
title_sort technological advances i cebpa i and i flt3 i internal tandem duplication mutations can be reliably detected by next generation sequencing
topic <i>CEBPA</i>
<i>FLT3</i>
AML
next generation sequencing (NGS)
Internal Tandem Duplication (ITD)
url https://www.mdpi.com/2073-4425/13/4/630
work_keys_str_mv AT ratilalakabari technologicaladvancesicebpaiandiflt3iinternaltandemduplicationmutationscanbereliablydetectedbynextgenerationsequencing
AT dahuiqin technologicaladvancesicebpaiandiflt3iinternaltandemduplicationmutationscanbereliablydetectedbynextgenerationsequencing
AT mohammadhussaini technologicaladvancesicebpaiandiflt3iinternaltandemduplicationmutationscanbereliablydetectedbynextgenerationsequencing